(Q44800567)

6 December 2017

title

First year experience of rotavirus immunisation programme in Finland (English)

1 reference

6 December 2017

0 references

Jukka Ollgren

2

0 references

author name string

Tuija Leino

1

1 reference

6 December 2017

Heini Salo

3

1 reference

6 December 2017

Petri Tiihonen

4

1 reference

6 December 2017

Terhi Kilpi

5

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 November 2012

1 reference

6 December 2017

1 reference

6 December 2017

volume

31

1 reference

6 December 2017

issue

1

1 reference

6 December 2017

page(s)

176-182

1 reference

Global Illness and Deaths Caused by Rotavirus Disease in Children

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.068

Burden of rotavirus disease in European Union countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.068

Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.068

Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.068

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.068

Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.068

Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.068

Effectiveness of rotavirus vaccine in preventing hospitalization due to rotavirus gastroenteritis in young children in Connecticut, USA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.068

Use of the state immunization information system to assess rotavirus vaccine effectiveness in Connecticut, 2006-2008.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.068

Effectiveness of pentavalent rotavirus vaccine against severe disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.068

Rotavirus vaccines in Belgium: policy and impact

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.068

Impact of rotavirus vaccination on hospitalizations for rotavirus diarrhea: The IVANHOE study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.068

Decline in cases of rotavirus gastroenteritis presenting to The Children's Hospital of Philadelphia after introduction of a pentavalent rotavirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.068

Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.068

Hospitalizations due to rotavirus gastroenteritis in Catalonia, Spain, 2003-2008.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.068

Hospitalisation for rotavirus gastroenteritis in the paediatric population in the Veneto Region, Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.068

Efficacy of RIX4414 live attenuated human rotavirus vaccine in Finnish infants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.068

Rotavirus gastroenteritis in Finland: burden of disease and epidemiological features.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.068

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2012.10.068

1 reference

6 December 2017

1 reference